Diploma PLC

Diploma PLC

DPLM.L
Diploma PLCGB flagLondon Stock Exchange
7,085.00
GBp
-115.00
- -
9.50BMarket Cap
Diploma PLC
DPLM.L
(London Stock Exchange)

Recent

price

7,085.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
FRC
1.63
2.05
2.32
2.54
2.71
2.95
3.38
3.99
4.29
4.81
4.75
6.33
8.13
9.26
10.17
11.37
Revenue per Share
0.19
0.24
0.28
0.31
0.31
0.32
0.34
0.42
0.48
0.55
0.43
0.56
0.76
0.91
0.96
1.38
Basic EPS, GAAP
0.21
0.23
0.29
0.32
0.35
0.37
0.48
0.5
0.52
0.52
0.67
0.88
0.88
1.28
1.33
1.89
Free Cash Flow per Basic Share
0.08
0.1
0.13
0.15
0.16
0.17
0.19
0.21
0.24
0.26
0.2
0.43
0.45
0.54
0.57
0.6
Dividend per Share
1.03
1.15
1.31
1.43
1.56
1.67
1.79
2.06
2.31
2.52
2.74
2.69
3.06
3.33
3.62
4.44
Book Value per Share
0.43
0.44
0.48
0.64
0.69
0.57
0.59
0.79
0.98
0.63
2.48
-0.55
-1.31
-0.47
-1.17
-0.38
Tangible Book Value per Share
113
112
112
112
113
113
113
113
113
113
113
124
125
130
134
134
Basic Weighted Avg Shares
184
231
260
286
306
334
383
452
485
545
538
787
1,013
1,200
1,363
1,524
Sales/Revenue/Turnover
15.69
17.52
17.83
17.06
16.45
15.85
14.48
15.16
15.09
15.44
12.96
13.25
14.25
15.48
15.17
18.69
Operating Margin (%)
2
2
2
2
2
4
4
5
5
5
13
21
24
29
32
30
Depreciation Expense
22
27
31
34
36
37
38
48
54
62
49
70
95
118
129
185
Net Income, GAAP
32.96
29.59
31.3
28.25
27.51
27.8
27.59
27.84
25.17
25.27
25.34
27.85
26.33
23.97
26.39
25.29
Effective Tax Rate (%)
11.72
11.71
12.03
12.08
11.61
10.99
10.01
10.51
11.09
11.36
9.16
8.86
9.35
9.81
9.48
12.13
Profit Margin (%)
45
48
50
65
74
80
72
88
106
113
275
117
166
252
318
310
Working Capital
- -
- -
- -
- -
- -
20
- -
- -
- -
42
26
227
396
382
539
450
LT Debt
139
152
167
178
187
195
238
267
294
325
531
541
668
902
895
994
Total Equity
14.46
18.83
18.92
19.51
19.5
18.54
16.91
18.7
18.96
18.45
10.95
10.89
11
11.63
11.01
14.51
Return on Invested Capital (%)
17.93
21.1
21.76
22.02
20.56
18.66
17.76
20.7
21.23
20.83
15.07
15.75
14.35
15.86
15.74
19.31
Return on Capital (%)
19.72
22.03
22.65
22.43
21.05
20.08
19.56
21.8
21.79
22.67
16.56
21.62
26.42
28.97
28.23
34.25
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
18.91%
14.15%
11.12%
Free Cash Flow
21.21%
29.05%
41.93%
Net Income, GAAP
19.07%
30.88%
43%
Sales/Revenue/Turnover
17%
23.76%
11.82%
Total Cash Common Dividend
19.53%
34.74%
5.08%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
1,363
2025
- -
- -
- -
- -
1,524
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.96
2025
- -
- -
- -
- -
1.38
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.57
2025
- -
- -
- -
- -
0.6
2026
- -
- -
- -
- -
- -
Business
Diploma PLC is a United Kingdom-based decentralized, value-add distributor specializing in critical technical products and services across three core sectors: Controls, Seals, and Life Sciences. The Controls sector offers wire and cables, interconnect solutions, specialty adhesives, specialty fasteners, and industrial automation equipment. The Seals sector provides sealing solutions and fluid power products supporting aftermarket repairs, original equipment manufacturing, and maintenance, repair, and overhaul projects. The Life Sciences segment supplies technology-driven, value-added solutions for in vitro diagnostics, scientific research, and medtech markets. Founded in 1931 and headquartered in London, Diploma operates with a strong international footprint spanning North America, Europe, the United Kingdom, and Australasia, with North America accounting for approximately 62% of group revenue. The company targets specialist end markets including aerospace, defense, datacenters, energy storage, healthcare, and industrial infrastructure. Recent strategic developments over the past two years include a vigorous acquisition program with seven acquisitions since the start of fiscal 2025, notably expanding its aerospace, defense, and in vitro diagnostics (IVD) market presence. Diploma has also invested substantially in innovation, allocating £1.5 million to R&D in 2023, resulting in the launch of three new product lines that enhanced revenue by 20% within six months. Operationally, the company has advanced its technology platform by implementing state-of-the-art inventory and customer relationship management systems, increasing customer engagement and reducing costs by double digits. Financially, it reported record revenues exceeding £1.5 billion in fiscal 2025, reflecting 11% organic growth, driven by strong performances in North America and strategic acquisitions. Adjusted operating margin improved to 22.5%, up 160 basis points, supported by operational leverage and enhanced portfolio quality. Diploma’s business model emphasizes a decentralized structure fostering customer-centricity and agility within specialist markets. Its strategic focus remains on expanding market share in high-growth sectors such as aerospace, defense, datacenters, energy storage, and healthcare, supported by ongoing complementary acquisitions and product extensions. The company’s multidisciplinary product range and geographic diversification underpin its resilient performance amidst evolving market conditions. Diploma PLC continues to leverage its heritage since 1931 and its robust operational capabilities to maintain leadership as a global provider of specialized technical products and value-added services. Diploma PLC’s headquarters are located at 10-11 Charterhouse Square, London, United Kingdom. It employs approximately 3,600 people worldwide and remains committed to sustainable growth and operational excellence through targeted investment in technology and acquisitions. The company’s client base includes original equipment manufacturers, maintenance and repair operators, research institutions, and technology-driven healthcare providers across multiple continents. This profile incorporates the latest financial results, strategic acquisitions, product innovations, and geographic expansion documented through fiscal year 2024 and 2025.